BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

AT&T and eCardio Diagnostics Team Up to Advance Cardiac Care Through Innovative Mobile Technology


10/7/2010 10:30:48 AM

HOUSTON, Oct. 7 /PRNewswire/ -- AT&T* and eCardio Diagnostics, one of the leading providers of arrhythmia monitoring solutions, today announced the combination of mobile technology with cardiac care to provide leading edge monitoring solutions for heart patients. AT&T is providing eCardio with machine-to-machine (M2M) wireless data and mobile connectivity for near real-time, remote monitoring of cardiac patients. eCardio's monitoring solution on cardiac devices allows heart patients to recover at home rather than spend additional time in the hospital.

eCardio has implemented the monitoring solution on almost 10,000 cardiac devices with plans to deploy it across thousands more over the next year. AT&T's wireless connectivity for the monitoring solution allows doctors to have critical patient information sent to them near real-time, as circumstances occur, helping them improve response times to heart issues. Clinical productivity is improved by timely access to accurate patient information from any Internet-enabled computer. Not only does the solution provide a better patient experience, it can also help hospitals, health insurance companies, pharmacies, drug retailers and research organizations lower their costs of treating arrhythmia patients.

eCardio offers an array of clinical services and leading-edge devices designed to simplify and streamline the process of arrhythmia monitoring. This allows physicians to make more precise diagnoses and enhance the follow-up and management of their patients. eCardio has served thousands of patients suffering from heart rhythm disorders and provided physicians with leading-edge diagnostic innovations and solutions that optimize the flexibility, speed and accuracy in the diagnoses of cardiac arrhythmias.

"We're focused on providing a total solution to physicians and patients. AT&T is helping us implement innovative mobile technologies that are transforming the field of diagnostic medicine and advancing arrhythmia treatments," said Andrew Arroyo, vice president, Information Technology at eCardio. "AT&T delivered the expertise and services we needed to create an end-to-end mobility solution that improves the patient experience and physician productivity."

Heart rhythm disorders, or arrhythmias, occur when the electrical impulses in the heart responsible for coordinating the heartbeats malfunction, causing the heart to beat irregularly. An arrhythmia may be brief and unnoticeable or it may be fatal. According to the American Heart Association, atrial fibrillation (AF) is the most common and serious rhythm abnormality in people over the age of 65.

*AT&T products and services are provided or offered by subsidiaries and affiliates of AT&T Inc. under the AT&T brand and not by AT&T Inc.

About eCardio

eCardio Diagnostics is one of the nation's leading providers of comprehensive and advanced technologies, devices, services and solutions for the diagnosis, monitoring and subsequent clinical management of cardiac arrhythmias, predominantly in an ambulatory setting. eCardio provides leading-edge diagnostic innovations and solutions that optimize the flexibility, speed and accuracy of cardiac arrhythmia diagnoses.

About AT&T

AT&T Inc. (NYSE: T) is a premier communications holding company. Its subsidiaries and affiliates AT&T operating companies are the providers of AT&T services in the United States and around the world. With a powerful array of network resources that includes the nation's fastest mobile broadband network, AT&T is a leading provider of wireless, Wi-Fi, high speed Internet and voice services. A leader in mobile broadband, AT&T also offers the best wireless coverage worldwide, offering the most wireless phones that work in the most countries. It also offers advanced TV services under the AT&T U-verse® and AT&T | DIRECTV brands. The company's suite of IP-based business communications services is one of the most advanced in the world. In domestic markets, AT&T Advertising Solutions and AT&T Interactive are known for their leadership in local search and advertising. In 2010, AT&T again ranked among the 50 Most Admired Companies by FORTUNE®magazine.

Additional information about AT&T Inc. and the products and services provided by AT&T subsidiaries and affiliates is available at the AT&T Web Site. This AT&T news release and other announcements are available at AT&T Newsroom, and as part of an RSS feed at AT&T RSS Feed. Or follow our news on Twitter @ATT. Find us on Facebook at the AT&T Facebook to discover more about our consumer and wireless services or at AT&T Small Business Facebook to discover more about our small business services.

© 2010 AT&T Intellectual Property. All rights reserved. Mobile broadband not available in all areas. AT&T, the AT&T logo and all other marks contained herein are trademarks of AT&T Intellectual Property and/or AT&T affiliated companies. All other marks contained herein are the property of their respective owners.

SOURCE AT&T Inc.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->